Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick K, Gower E, Kempen J, Wolff J. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick K, Gower E, Kempen J, Wolff J
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The annual governmental budgetary impact of major adult visual disorders is estimated to be at least $13.7 billion  
  • Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.  
  • By 2020, the number of Americans age 40 and older who are blind is projected to reach 1.6 million– growing 70% from 1 million in 2004.  
  • More than 2 million Americans age 50 and older have age-related macular degeneration (AMD)—2,069,403.  
  • An estimated 4.1 million Americans age 40 and older have diabetic retinopathy.